Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN) - Pathmanandavel, S; Crumbaker, M; Ho, B (J Nucl Med, 2023)